Department of Anesthesiology, Intensive Care and Dermatology, University of Milan, Milan, Italy.
Minerva Anestesiol. 2009 Oct;75(10):584-90.
Many years after the introduction of the protected specimen brush (PSB) by Wimberley et al. as a tool to diagnose ventilator associated pneumonia (VAP), new sampling techniques have increased the controversy concerning the diagnosis of VAP. Agreement exists only on the high sensibility and low specificity of the clinical symptoms combined with imaging data. However, sampling methods, qualitative/quantitative microbiological evaluation and the value of ''markers'' still appear to be unresolved issues. Because a proven diagnosis is very rare, a more pragmatic approach to VAP diagnosis seems necessary. More specifically, the questions we must focus on include the following: ''Which patients with possible pneumonia or lower respiratory infection require antibiotic treatment ?'' and ''In which patients with possible/suspected VAP is empiric treatment not immediately necessary and for which of these patients can empiric treatment be limited or discontinued?''
许多年以后,Wimberley 等人引入保护性标本刷(PSB)作为诊断呼吸机相关性肺炎(VAP)的工具,新的采样技术增加了 VAP 诊断方面的争议。目前仅就临床症状结合影像学数据的高灵敏度和低特异性达成一致。然而,采样方法、定性/定量微生物学评估和“标志物”的价值似乎仍然是悬而未决的问题。由于确诊的病例非常罕见,因此似乎需要对 VAP 的诊断采取更务实的方法。更具体地说,我们必须关注的问题包括:“哪些可能患有肺炎或下呼吸道感染的患者需要抗生素治疗?”和“在哪些可能/疑似 VAP 的患者中,经验性治疗并非立即必要,对于这些患者中的哪些患者,可以限制或停止经验性治疗?”